Department of Chemical and Biological Engineering,
College of Engineering,
Nanovaccine Institute,
Department of Chemical and Biological Engineering, College of Engineering
Balaji Narasimhan has not added Biography.
If you are Balaji Narasimhan and would like to personalize this page please email our Author Liaison for assistance.
Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides.
Journal of controlled release : official journal of the Controlled Release Society Jul, 2002 | Pubmed ID: 12106982
Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery.
Biomaterials Nov, 2002 | Pubmed ID: 12219831
Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres.
Journal of controlled release : official journal of the Controlled Release Society Jan, 2004 | Pubmed ID: 14684277
Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres.
Journal of controlled release : official journal of the Controlled Release Society Nov, 2004 | Pubmed ID: 15491814
Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms.
Journal of biomedical materials research. Part A Jan, 2006 | Pubmed ID: 16138330
Characterization of fate and transport of isoxaflutole, a soil-applied corn herbicide, in surface water using a watershed model.
Journal of agricultural and food chemistry Nov, 2005 | Pubmed ID: 16248595
Parallel synthesis and high throughput dissolution testing of biodegradable polyanhydride copolymers.
Journal of combinatorial chemistry Nov-Dec, 2005 | Pubmed ID: 16283803
Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
Journal of biomedical materials research. Part A Mar, 2006 | Pubmed ID: 16345084
Problem-based learning biotechnology courses in chemical engineering.
Biotechnology progress Jan-Feb, 2006 | Pubmed ID: 16454508
Protein stability in the presence of polymer degradation products: consequences for controlled release formulations.
Biomaterials Jun, 2006 | Pubmed ID: 16504288
Amphiphilic polyanhydrides for protein stabilization and release.
Biomaterials Jan, 2007 | Pubmed ID: 16965812
The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.
Journal of microencapsulation Dec, 2006 | Pubmed ID: 17390625
Immunomodulatory biomaterials.
International journal of pharmaceutics Dec, 2008 | Pubmed ID: 18662761
Vaccine adjuvants: current challenges and future approaches.
Journal of pharmaceutical sciences Apr, 2009 | Pubmed ID: 18704954
Combinatorial design of biomaterials for drug delivery: opportunities and challenges.
Expert opinion on drug delivery Aug, 2008 | Pubmed ID: 18712994
Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.
Pharmaceutical research Mar, 2009 | Pubmed ID: 18987960
Cobalt ferrite nanocrystals: out-performing magnetotactic bacteria.
ACS nano Oct, 2007 | Pubmed ID: 19206653
High throughput cell-based screening of biodegradable polyanhydride libraries.
Combinatorial chemistry & high throughput screening Aug, 2009 | Pubmed ID: 19531023
The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells.
Biomaterials Oct, 2009 | Pubmed ID: 19539989
Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.
Journal of biomedical materials research. Part B, Applied biomaterials Nov, 2009 | Pubmed ID: 19642209
Combinatorial/high throughput methods for the determination of polyanhydride phase behavior.
Journal of combinatorial chemistry Sep-Oct, 2009 | Pubmed ID: 19691268
Tracking chemical processing pathways in combinatorial polymer libraries via data mining.
Journal of combinatorial chemistry Mar, 2010 | Pubmed ID: 20030378
Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.
Acta biomaterialia Aug, 2010 | Pubmed ID: 20123135
Lipocalin-2-loaded Amphiphilic Polyanhydride Microparticles Accelerate Cell Migration.
Journal of biomaterials science. Polymer edition Jul, 2010 | Pubmed ID: 20615357
Protein adsorption on biodegradable polyanhydride microparticles.
Journal of biomedical materials research. Part A Oct, 2010 | Pubmed ID: 20740599
Mathematical modeling of polymer erosion: consequences for drug delivery.
International journal of pharmaceutics Oct, 2011 | Pubmed ID: 21130849
Identifying factors controlling protein release from combinatorial biomaterial libraries via hybrid data mining methods.
ACS combinatorial science Jan, 2011 | Pubmed ID: 21247125
Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases.
PloS one , 2011 | Pubmed ID: 21408610
Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
Acta biomaterialia Jul, 2011 | Pubmed ID: 21439412
A novel high throughput method to investigate polymer dissolution.
Macromolecular rapid communications Feb, 2010 | Pubmed ID: 21590918
Amphiphilic polyanhydride films promote neural stem cell adhesion and differentiation.
Tissue engineering. Part A Oct, 2011 | Pubmed ID: 21599544
Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants.
Biomaterials Oct, 2011 | Pubmed ID: 21703679
Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
Molecular pharmaceutics Oct, 2011 | Pubmed ID: 21882825
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
Scientific reports , 2011 | Pubmed ID: 22355713
Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles.
Biomaterials Jun, 2012 | Pubmed ID: 22465338
Chemistry-dependent adsorption of serum proteins onto polyanhydride microparticles differentially influences dendritic cell uptake and activation.
Acta biomaterialia Jun, 2012 | Pubmed ID: 22684115
Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses.
Journal of biomedical materials research. Part B, Applied biomaterials Jan, 2013 | Pubmed ID: 23143744
Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.
Acta biomaterialia Mar, 2013 | Pubmed ID: 23153760
Block copolymer-quantum dot micelles for multienzyme colocalization.
Langmuir : the ACS journal of surfaces and colloids Dec, 2012 | Pubmed ID: 23171402
Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.
Advanced healthcare materials Feb, 2013 | Pubmed ID: 23184561
Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.
Acta biomaterialia Sep, 2013 | Pubmed ID: 23774257
Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells.
Acta biomaterialia Nov, 2013 | Pubmed ID: 23796408
Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.
International journal of nanomedicine , 2013 | Pubmed ID: 23818778
Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Journal of controlled release : official journal of the Controlled Release Society Dec, 2013 | Pubmed ID: 24140748
Materials-based strategies for multi-enzyme immobilization and co-localization: A review.
Biotechnology and bioengineering Feb, 2014 | Pubmed ID: 24142707
Facile fabrication of polyanhydride/anesthetic nanoparticles with tunable release kinetics.
Advanced healthcare materials Jun, 2014 | Pubmed ID: 24376136
A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.
Scientific reports Jan, 2014 | Pubmed ID: 24441019
Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.
Journal of biomedical materials research. Part A Nov, 2014 | Pubmed ID: 24443139
Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.
Advanced healthcare materials Jul, 2014 | Pubmed ID: 24520022
Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems.
Journal of controlled release : official journal of the Controlled Release Society Sep, 2014 | Pubmed ID: 24998939
Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.
Nanoscale Nov, 2014 | Pubmed ID: 25285425
Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles.
Pharmaceutical research Apr, 2015 | Pubmed ID: 25297714
Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.
The AAPS journal Jan, 2015 | Pubmed ID: 25421457
Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity.
International journal of nanomedicine , 2015 | Pubmed ID: 25565816
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.
Nanomedicine : nanotechnology, biology, and medicine Apr, 2015 | Pubmed ID: 25645958
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.
Nanomedicine : nanotechnology, biology, and medicine Apr, 2015 | Pubmed ID: 25652894
Nano-enabled delivery of diverse payloads across complex biological barriers.
Journal of controlled release : official journal of the Controlled Release Society Dec, 2015 | Pubmed ID: 26315817
Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation.
Journal of controlled release : official journal of the Controlled Release Society Dec, 2015 | Pubmed ID: 26410807
Polyanhydride Nanoparticle Delivery Platform Dramatically Enhances Killing of Filarial Worms.
PLoS neglected tropical diseases , 2015 | Pubmed ID: 26496201
Rational Design of Targeted Next-Generation Carriers for Drug and Vaccine Delivery.
Annual review of biomedical engineering 07, 2016 | Pubmed ID: 26789697
Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology Jun, 2016 | Pubmed ID: 26838361
Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses.
Journal of biomedical nanotechnology Jun, 2016 | Pubmed ID: 27319223
Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.
Nanomedicine : nanotechnology, biology, and medicine Oct, 2016 | Pubmed ID: 27771430
Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs.
Journal of controlled release : official journal of the Controlled Release Society 02, 2017 | Pubmed ID: 28057521
The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Acta biomaterialia 03, 2017 | Pubmed ID: 28063991
Polyanhydride nanovaccine against swine influenza virus in pigs.
Vaccine 02, 2017 | Pubmed ID: 28117173
Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.
Antioxidants & redox signaling Apr, 2017 | Pubmed ID: 28375739
Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.
Journal of biomedical materials research. Part A Oct, 2017 | Pubmed ID: 28556563
Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases.
Journal of biomedical materials research. Part A 04, 2018 | Pubmed ID: 29226615
Emerging trends in the immunotherapy of pancreatic cancer.
Cancer letters 03, 2018 | Pubmed ID: 29242097
Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics.
Biomedical materials (Bristol, England) 02, 2018 | Pubmed ID: 29332842
A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers.
Vaccine 02, 2018 | Pubmed ID: 29413092
A polyanhydride-based implantable single dose vaccine platform for long-term immunity.
Vaccine 02, 2018 | Pubmed ID: 29413093
pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.
Biomacromolecules 03, 2018 | Pubmed ID: 29443509
Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.
Scientific reports 02, 2018 | Pubmed ID: 29445124
Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.
Frontiers in immunology , 2018 | Pubmed ID: 29599766
Automated High-Throughput Synthesis of Protein-Loaded Polyanhydride Nanoparticle Libraries.
ACS combinatorial science 05, 2018 | Pubmed ID: 29617113
Intranasal delivery of influenza antigen by nanoparticles, but not NKT-cell adjuvant differentially induces the expression of B-cell activation factors in mice and swine.
Cellular immunology 07, 2018 | Pubmed ID: 29665972
Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.
Frontiers in immunology , 2018 | Pubmed ID: 30233573
Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses.
The Journal of pharmacology and experimental therapeutics 09, 2019 | Pubmed ID: 30361239
Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.
Journal of biomedical materials research. Part A 11, 2018 | Pubmed ID: 30369055
Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases.
International journal of pharmaceutics Jan, 2019 | Pubmed ID: 30448309
Surface engineered polyanhydride-based oral subunit nanovaccine for poultry.
International journal of nanomedicine , 2018 | Pubmed ID: 30555234
Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections.
Journal of controlled release : official journal of the Controlled Release Society 01, 2019 | Pubmed ID: 30572034
Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice.
Biomaterials science Feb, 2019 | Pubmed ID: 30663733
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
Journal for immunotherapy of cancer 03, 2019 | Pubmed ID: 30890189
Design and synthesis of multivalent α-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of infection.
Beilstein journal of organic chemistry , 2019 | Pubmed ID: 30931004
Safety and biocompatibility of injectable vaccine adjuvants composed of thermogelling block copolymer gels.
Journal of biomedical materials research. Part A 08, 2019 | Pubmed ID: 30972906
STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice.
Vaccine 05, 2019 | Pubmed ID: 30987850
Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.
Genes & cancer May, 2019 | Pubmed ID: 31258832
Effective mosaic-based nanovaccines against avian influenza in poultry.
Vaccine 08, 2019 | Pubmed ID: 31300285
Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.
Nanomedicine : nanotechnology, biology, and medicine 10, 2019 | Pubmed ID: 31319179
Sustained antigen release polyanhydride-based vaccine platform for immunization against bovine brucellosis.
Heliyon Aug, 2019 | Pubmed ID: 31517098
Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.
Acta biomaterialia 12, 2019 | Pubmed ID: 31610342
Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves.
Scientific reports 10, 2019 | Pubmed ID: 31641172
Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.
Journal of animal science 06, 2020 | Pubmed ID: 31889177
High-Throughput Synthesis and Screening of Rapidly Degrading Polyanhydride Nanoparticles.
ACS combinatorial science 04, 2020 | Pubmed ID: 32125826
A single dose polyanhydride-based nanovaccine against paratuberculosis infection.
NPJ vaccines , 2020 | Pubmed ID: 32128256
Chitosan-adjuvanted Salmonella subunit nanoparticle vaccine for poultry delivered through drinking water and feed.
Carbohydrate polymers Sep, 2020 | Pubmed ID: 32532387
Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β.
Journal of biomedical materials research. Part A Jun, 2021 | Pubmed ID: 32776461
Biodistribution of degradable polyanhydride particles in Aedes aegypti tissues.
PLoS neglected tropical diseases 09, 2020 | Pubmed ID: 32898130
Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8 T Cell Memory and Delayed Tumor Progression.
International journal of nanomedicine , 2020 | Pubmed ID: 32982219
Corrigendum to: Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.
Journal of animal science 11, 2020 | Pubmed ID: 33151332
Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.
Current topics in microbiology and immunology Nov, 2020 | Pubmed ID: 33165869
Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease Patients.
ACS chemical neuroscience 12, 2020 | Pubmed ID: 33196164
Applications of Nanovaccines for Disease Prevention in Cattle.
Frontiers in bioengineering and biotechnology , 2020 | Pubmed ID: 33363134
Pentablock Copolymer Micelle Nanoadjuvants Enhance Cytosolic Delivery of Antigen and Improve Vaccine Efficacy while Inducing Low Inflammation.
ACS biomaterials science & engineering Mar, 2019 | Pubmed ID: 33405651
Polyanhydride Nanoparticle Interactions with Host Serum Proteins and Their Effects on Bone Marrow Derived Macrophage Activation.
ACS biomaterials science & engineering Feb, 2017 | Pubmed ID: 33450792
Synthesis and Characterization of Rapidly Degrading Polyanhydrides as Vaccine Adjuvants.
ACS biomaterials science & engineering 01, 2020 | Pubmed ID: 33463223
A single dose polyanhydride-based nanovaccine against paratuberculosis infection.
NPJ vaccines Feb, 2020 | Pubmed ID: 33580082
Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.
Journal of immunology (Baltimore, Md. : 1950) May, 2021 | Pubmed ID: 33827894
Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis.
Vaccine 06, 2021 | Pubmed ID: 34090702
M. M. Hasibuzzaman1,2,
Kathleen A. Ross3,4,
Aliasger K. Salem1,4,5,6,
Balaji Narasimhan3,4,
Andrean L. Simons1,2,3,5,6,7
1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa,
2Department of Pathology, University of Iowa,
3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University,
4Nanovaccine Institute, Iowa State University,
5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa,
6Holden Comprehensive Cancer Center, University of Iowa,
7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados